Immune responses in chickens against Eimeria tenella sporozoite antigen.

R. Garg,D. Banerjee,S. Gupta

DOI: https://doi.org/10.1016/S0304-4017(98)00231-3

IF: 2.821

1999-02-01

Veterinary Parasitology

Abstract:

What problem does this paper attempt to address?

CEREBRO-VASCULAR DISEASE AS A CAUSE OF FALLS IN THE ELDERLY.

L. Brain

DOI: https://doi.org/10.1159/000244828

Gerontologia Clinica

Abstract:
Rotational Thromboelastometry-Guided Venoarterial Extracorporeal Membrane Oxygenation in the Treatment of Amniotic Fluid Embolism

Jillian K Wothe,Elizabeth Elfstrand,Michael R Mooney,Donald D Wothe

DOI: https://doi.org/10.1155/2022/9658708

2022-05-18

Abstract:Amniotic fluid embolism (AFE) is a rare and often fatal complication of pregnancy that occurs during the puerperium. The low incidence of AFE has resulted in few large studies, which makes evidence-based management of AFE challenging. The use of extracorporeal membrane oxygenation (ECMO) has been reported but is limited by availability and challenges managing anticoagulation. In this report, we detail the case of a 29-year-old female who suffered from an AFE leading to cardiac arrest and disseminated intravascular coagulopathy. She was treated with protocolized A-OK (adenosine, ondansetron, and ketorolac), emergency c-section, cardiopulmonary resuscitation, massive blood transfusion, and rotational thromboelastometry-guided ECMO, allowing her to forgo initial anticoagulation. After a prolonged rehabilitation with initial poor neurological status, she made a complete recovery. In this report, we describe the protocols that contributed to her recovery and detail management of complicated AFE for other clinicians.
A novel extraction chromatography and MC-ICP-MS technique for rapid analysis of REE, Sc and Y: Revising CI-chondrite and Post-Archean Australian Shale (PAAS) abundances

A. Pourmand,N. Dauphas,T. Ireland

DOI: https://doi.org/10.1016/J.CHEMGEO.2011.08.011

2012-01-06

Abstract:
Extracorporeal Cardiopulmonary Resuscitation for Amniotic Fluid Embolism

Courtney Stanley Sundin,Laura Gomez,Brian Chapman

DOI: https://doi.org/10.1097/nmc.0000000000000970

2024-01-01

Abstract:Abstract Amniotic fluid embolism (AFE) is a rare, sudden, and catastrophic complication of pregnancy that can result in cardiopulmonary arrest, potentially leading to death. The pathophysiology of an AFE includes an inflammatory and coagulopathic response due to fetal materials entering maternal circulation with the hallmark triad of symptoms: acute respiratory distress, cardiovascular collapse, and coagulopathy. Management of AFE should include high-quality cardiopulmonary resuscitation, immediate delivery of the fetus if applicable, early intubation to provide adequate oxygenation and ventilation, fluid volume resuscitation, and ongoing evaluation of coagulopathy. Priorities include thromoboelastography interpretation if available, control of hemorrhage and coagulopathy with blood component therapy, and cardiovascular support through inotropes and vasopressor administration. More recent approaches include implementing the A-OK (atropine, ondansetron, and ketorolac) protocol for suspected AFE protocol, extracorporeal cardiopulmonary resuscitation (ECPR), and extracorporeal membrane oxygenation (ECMO) therapies to increase survival and decrease complications. Venoarterial ECMO is the highest form of life support that provides support in patients with pulmonary and cardiac failure. ECPR is the application of Venoarterial ECMO during cardiopulmonary resuscitation in cases where the cause of arrest is believed to be reversible. Early implementation of ECPR during the acute phase of AFE can provide support for end-organ perfusion in place of the weakened and recovering heart while optimizing oxygenation, making venoarterial ECMO an ideal adjunctive therapy. Because of the rarity of AFE, many obstetrical teams may have limited prior experience in managing these catastrophic cases; however, with ongoing education and simulation, teams can be better prepared in the recognition and management of these life-threatening events.

nursing
Extracorporeal Membrane Oxygenation in Amniotic Fluid Embolism: A Systematic Review of Case Reports

Ngan Hoang Kim Trieu,Nam Nhat Nguyen,Huy Minh Pham,Dai Quang Huynh,Anh Tuan Mai

DOI: https://doi.org/10.1097/MAT.0000000000002269

2024-07-09

Abstract:Amniotic fluid embolism (AFE) is an obstetric complication that can result in acute circulatory failure during and after labor. The effectiveness of extracorporeal membrane oxygenation (ECMO) in AFE patients has not been established, especially in the context of coagulopathy. This review aims to evaluate the efficacy of ECMO support in AFE patients. We conducted a systematic review of case reports following the Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Quality assessment was performed using a standardized tool. Out of 141 studies screened, 33 studies included 79 AFE patients. The median age was 34 years, and the median gestational age was 37.5 weeks. The majority of AFE cases occurred during cesarean section delivery (55.2%), followed by labor before fetal delivery (26.7%). Extracorporeal membrane oxygenation configurations included venoarterial ECMO (81.3%) and extracorporeal cardiopulmonary resuscitation (CPR, 10.7%). The maternal survival rate was 72%, with 21.2% experiencing minor neurological sequelae and 5.8% having major neurological sequelae. Rescue ECMO to support circulation has demonstrated both safety and efficacy in managing AFE. We suggest early activation of local or mobile ECMO as soon as an AFE diagnosis is established. Further studies are needed to assess the benefits and implications of early ECMO support in AFE patients.
Resuscitative endovascular balloon occlusion of the aorta: A novel approach for treating amniotic fluid embolism with disseminated intravascular coagulopathy—A report of two cases

Tensei Ryu,Yusuke Kurokawa,Nobuhisa Hirayu,Megumi Muto,Jun Akiba,Hideaki Uzu,Takashi Horinouchi,Toshiyuki Yoshizato,Osamu Takasu,Naotake Tsuda

DOI: https://doi.org/10.1111/jog.16007

2024-06-26

Journal of Obstetrics and Gynaecology Research

Abstract:We present two critical cases of life‐threatening postpartum hemorrhage (PPH) due to amniotic fluid embolism (AFE) complicated by disseminated intravascular coagulopathy (DIC). These cases are the first to show the effectiveness of resuscitative endovascular balloon occlusion of the aorta (REBOA) for patient survival. In Case 1, the patient, experiencing critical conditions with severe PPH and DIC despite conventional treatments, including rapid blood transfusion and fibrinogen concentrate, was air‐transferred to our hospital, where REBOA was promptly employed before hysterectomy was completed. Case 2 involved an ambulance‐transferred patient with massive PPH and DIC despite conventional treatments. Prehospital REBOA was performed to prevent cardiac arrest during transfer, and hysterectomy was performed in the hospital. Given the rapid deterioration associated with AFE, REBOA can serve as a bridge until complete hemostasis to maintain vital signs and control bleeding in patients unresponsive to standard therapies before hemostatic interventions or during transfer.

obstetrics & gynecology
A case of amniotic fluid embolism successfully treated by multidisciplinary treatment

Yuki Kinishi,Chiyo Ootaki,Takeshi Iritakenishi,Yuji Fujino

DOI: https://doi.org/10.1186/s40981-019-0296-0

2019-11-28

Abstract:Background: Amniotic fluid embolism (AFE) is a life-threatening obstetric emergency. Because the maternal mortality associated with AFE is very high, early recognition and prompt treatment are important for improving the prognosis. We report a case of amniotic fluid embolism successfully treated by multidisciplinary treatment. Case presentation: A 39-year-old woman with fetal congenital heart anomaly and polyhydramnios was scheduled for induction of delivery at 37 weeks of gestation with labor epidural analgesia. Uncontrollable bleeding occurred 30 min after vaginal delivery. Based on the clinical diagnosis of AFE, massive blood transfusion, insertion of an aortic occlusion balloon catheter, and hysterectomy was performed. Total blood loss was 12,000 mL. The diagnosis of AFE was confirmed by pathological examination. She was discharged with no complications. Conclusion: We report a case of AFE who were rescued by prompt diagnosis and treatment.
Bone mineral density in an outpatient population receiving enzyme-inducing antiepileptic drugs

A. Pack,Lucia S. Olarte,M. Morrell,E. Flaster,S. Resor,E. Shane

DOI: https://doi.org/10.1016/S1525-5050(03)00036-2

IF: 3.337

2003-04-01

Epilepsy & Behavior

Abstract:
Extracorporeal Membrane Oxygenation-First Strategy for Acute Life-Threatening Pulmonary Embolism

Zhenjie Liu,Jinyi Chen,Xin Xu,Fen Lan,Minzhi He,Changming Shao,Yongshan Xu,Pan Han,Yibing Chen,Yongbin Zhu,Man Huang

DOI: https://doi.org/10.3389/fcvm.2022.875021

IF: 3.6

2022-01-01

Frontiers in Cardiovascular Medicine

Abstract:BackgroundBoth venoarterial extracorporeal membrane oxygenation (VA-ECMO) and percutaneous mechanical thrombectomy (PMT) are increasingly used to treat acute life-threatening pulmonary embolism (PE). However, there are little data regarding their effectiveness. This study aimed to present the short-term outcomes after managing nine patients with acute life-threatening massive or submassive PE by VA-ECMO with or without complemented PMT and propose a preliminary treatment algorithm. MethodsThis study was a single-center retrospective review of a prospectively maintained registry. It included nine consecutive patients with massive or submassive pulmonary embolism who underwent VA-ECMO for initial hemodynamic stabilization, with or without PMT, from August 2018 to November 2021. ResultsMean patient age was 54.7 years. Four of nine patients (44.4%) required cardiopulmonary resuscitation before or during VA-ECMO cannulation. All cannulations (100%) were successfully performed percutaneously. Overall survival was 88.9% (8 of 9 patients). One patient died from a hemorrhagic stroke. Of the survivors, the median ECMO duration was 8 days in patients treated with ECMO alone and 4 days in those treated with EMCO and PMT. Five of nine patients (55.6%) required concomitant PMT to address persistent right heart dysfunction, with the remaining survivors (44.4%) receiving VA-ECMO and anticoagulation alone. For survivors receiving VA-ECMO plus PMT, median hospital lengths of stay were 7 and 13 days, respectively. ConclusionsAn ECMO-first strategy complemented with PMT can be performed effectively and safely for acute life-threatening massive or submassive PE. VA-ECMO is feasible for initial stabilization, serving as a bridge to therapy primarily in inoperable patients with massive PE. Further evaluation in a larger cohort of patients is warranted to assess whether VA-ECMO plus PMT may offer an alternative or complementary therapy to thrombolysis or surgical thrombectomy. Type of ResearchSingle-center retrospective review of a prospectively maintained registry.
Case Report: AngioJet Thrombectomy with Extracorporeal Membrane Oxygenation Support for Acute Massive Pulmonary Embolism in a Severe Multiple Trauma Patient

Lun Tian,Libin Zhang,Naiding Zhang,Xin Xu,Yongshan Xu,Zhenjie Liu,Man Huang

DOI: https://doi.org/10.3389/fmed.2022.989613

IF: 3.9

2022-01-01

Frontiers in Medicine

Abstract:Acute massive pulmonary embolism (PE) is one of the main leading causes of high cardiovascular mortality, and the prognosis strongly varies, depending on the severity of pulmonary arterial obstruction and its impact on the RV function. Alternative therapy approaches comprise systemic thrombolysis, catheter-directed thrombolysis, catheter embolectomy, catheter-assisted fragmentation techniques, and surgical thrombectomy. The following case study explores a 72-year-old man with severe multiple trauma who suffered from a sudden massive pulmonary embolism and presented with an unstable hemodynamic status. Extracorporeal membrane oxygenation (ECMO) has amply proven its efficacy in supplying cardiopulmonary assistance for this patient shocked by a massive PE with contraindication for thrombolysis. AngioJet catheter embolectomy and ECMO were performed, which finally cleared the massive pulmonary embolism away and improved the patient's hemodynamic status. The use of ECMO was continued during the weaning program, on the fifth day after ECMO decannulation, the patient was extubated and transferred to a local hospital for further recuperation. This case highlights that the AngioJet thrombectomy with the combination use of ECMO may be a potential choice of treatment for unstable PE patients.
Successful recovery after amniotic fluid embolism in a patient undergoing vacuum-assisted vaginal delivery

Eric M Wise,Ricky Harika,Fatima Zahir

DOI: https://doi.org/10.1016/j.jclinane.2016.06.021

Abstract:Amniotic fluid embolism (AFE) is a rare, catastrophic emergency that requires prompt recognition and treatment. Despite early recognition and supportive therapy, the morbidity and mortality remain high. We report a case of AFE after vacuum-assisted vaginal delivery resulting in hemodynamic collapse and subsequent multiorgan failure. Management included mechanical ventilation, extracorporeal membrane oxygenation, and continuous veno-venous hemodialysis. The patient was able to make a full recovery with minimal sequelae. In AFE with multiorgan failure, extracorporeal membrane oxygenation and continuous veno-venous hemodialysis can be valuable therapies. Proper management requires effective communication and the combined efforts of physicians of several disciplines.
Amniotic Fluid Embolism Followed by Cardiac Arrest- A Case Report and Review of the Literature

Ningning Cheng,Yiheng Liang,Shangrong Fan,Shaomei Yan

DOI: https://doi.org/10.3877/cma.j.issn.2095-3259.2020.01.009

2020-01-01

Abstract:Objective To explore the clinical features, diagnosis, treatment and the outcome of amniotic fluid embolism (AFE). Methods We retrospectivly studied the clinical manifestation, diagnosis, treatment and the outcome of 1 case of AFE in Peking University Shenzhen Hospital and previous 61 literature reports. Results We reported a case of AFE followed by cardiac arrest in a 39 years old woman who was admitted to the hospital with premature rupture of membranes at 39 weeks of gestation. Cardiopulmonary resuscitation and cesarean were performed immediately. The patient and the infant were healthy. The common aura symptoms of patients with AFE included polypnea (27 cases, 44.3%), cyanosis (14 cases, 21.3%), drop of blood pressure (11 cases, 18.0%), altered mental status (9 cases, 14.8%) and dysphoria (8 cases, 13.1%). The common clinical manifestations were circulatory dysfunction (52 cases, 85.2%), respiratory dysfunction (47 cases, 77.0%) and blood dysfunction (39 cases, 63.9%). Eight cases (13.1%) used extracorporeal membrane oxygenation (ECMO), and the prognosis was excellent. Of the 61 patients with AFE, 16 cases (26.2%) died and 45 cases (73.8%) survived. There are 35 cases described neonatal outcome, 24 cases(57.4%)were healthy, 4 cases (6.6%) were dead, 7 cases (11.5%) were transferred to the neonatal intensive care unit (NICU) and the outcome was unknown. Conclusions The main manifestations of AFE are circulatory failure, respiratory failure and coagulation failure. Early identification, high quality cardiopulmonary resuscitation and opportune termination of pregnancy are the main treatment methods. Key words: Amniotic fluid embolism; Pregnancy complications; Cardiac arrest
Early Diagnosis of the Cardiopulmonary Collapse Type of Amniotic Fluid Embolism with Obstetrical Disseminated Intravascular Coagulation during Elective Cesarean Section : A Case Report

Yuki Ishikawa,Yuki Hari,Chiaki Murakami,Yasuhito Honda,Takuro Oyama,Ryosuke Kawanishi,Nami Kakuta,Yoko Sakai,Takashi Kaji,Yasuo M Tsutsumi,Katsuya Tanaka

DOI: https://doi.org/10.2152/jmi.67.207

Abstract:Two types of amniotic fluid embolism (AFE) have been described : cardiopulmonary collapse type and disseminated intravascular coagulation (DIC) type, with the latter proposed as uterine type. This report describes a healthy 28-year-old woman who developed AFE during a cesarean section. Because of a previous cesarean section, the patient underwent an elective cesarean section, under combined spinal-epidural anesthesia, at 38 weeks of pregnancy. She began coughing 5 minutes after delivery of the fetus, subsequently becoming unconscious and developing glossoptosis and bradycardia. Her blood pressure decreased to 76/43 mmHg, and AFE was suspected. Her uterus was atonic, and she experienced persistent noncoagulant bleeding, with a final blood loss of 6300 ml. Considerable blood transfusion was required. The patient survived, and she and her baby were discharged without any sequelae on the eighth postoperative day. This patient met the Japanese criteria for clinical AFE, with an obstetrical DIC score of 21 meeting the criteria for obstetrical DIC. Early diagnosis and treatment likely resulted in patient survival. J. Med. Invest. 67 : 207-210, February, 2020.
Electrochemical biomineralization: the deposition of calcite with chiral morphologies.

Elizabeth A. Kulp,J. Switzer

DOI: https://doi.org/10.1021/JA076303B

IF: 15

2007-11-16

Journal of the American Chemical Society

Abstract:The biominerals calcite and aragonite are electrodeposited by electrochemically generating base in a solution containing Ca2+ and HCO3-. Although calcite crystallizes in the achiral space group R3c, orientations of calcite which lack mirror or glide plane symmetry are chiral. Chiral morphologies of calcite are electrodeposited in the presence of tartaric, malic, and aspartic acid. Calcite grows with left-handed spirals when deposited from l-tartaric acid but grows with right-handed spirals when deposited from l-malic acid or l-aspartic acid. A racemic mixture of d- and l-malic acid produces an achiral microstructure, instead of producing a racemic mixture of chiral microstructures.
Design of new promoters and of a dual-bioreporter based on cross-activation by the two regulatory proteins XylR and HbpR.

D. Tropel,A. Bähler,Kathrin Globig,J. R. van der Meer

DOI: https://doi.org/10.1111/J.1462-2920.2004.00645.X

IF: 5.476

2004-11-01

Environmental Microbiology

Abstract:The HbpR protein is the sigma54-dependent transcription activator for 2-hydroxybiphenyl degradation in Pseudomonas azelaica. The ability of HbpR and XylR, which share 35% amino acid sequence identity, to cross-activate the PhbpC and Pu promoters was investigated by determining HbpR- or XylR-mediated luciferase expression and by DNA binding assays. XylR measurably activated the PhbpC promoter in the presence of the effector m-xylene, both in Escherichia coli and Pseudomonas putida. HbpR weakly stimulated the Pu promoter in E. coli but not in P. azelaica. Poor HbpR-dependent activation from Pu was caused by a weak binding to the operator region. To create promoters efficiently activated by both regulators, the HbpR binding sites on PhbpC were gradually changed into the XylR binding sites of Pu by site-directed mutagenesis. Inducible luciferase expression from mutated promoters was tested in E. coli on a two plasmid system, and from mono copy gene fusions in P. azelaica and P. putida. Some mutants were efficiently activated by both HbpR and XylR, showing that promoters can be created which are permissive for both regulators. Others achieved a higher XylR-dependent transcription than from Pu itself. Mutants were also obtained which displayed a tenfold lower uninduced expression level by HbpR than the wild-type PhbpC, while keeping the same maximal induction level. On the basis of these results, a dual-responsive bioreporter strain of P. azelaica was created, containing both XylR and HbpR, and activating luciferase expression from the same single promoter independently with m-xylene and 2-hydroxybiphenyl.
Amniotic fluid embolism: A case report of good outcome with timely intensive multidisciplinary team involvement

Caroline Lim,Charles Tsung-Che Hsieh,Siew Yen Lai,Yi-Tzu Chu,Ming Chen,Hsin-Hung Wu

DOI: https://doi.org/10.1016/j.tjog.2023.05.015

Abstract:Objective: Amniotic fluid embolism is one of the most serious pregnancy complications. It can cause sudden maternal collapse with high mortality and morbidity. We present a case report regarding the important of prompt decision making and multidisciplinary team work for management of amniotic fluid embolism to yield favorable maternal and neonatal outcome. Case report: This is a 35-year-old, gravida 2, para 1, woman underwent labor induction at gestational age of 37 + 6 weeks due to elective induction. She had sudden facial cyanosis and shortness of breath right after artificial rupture of membrane. Prompt decision of urgent cesarean section, aggressive and timely massive blood transfusion and multidisciplinary team work had spared patient from extracorporeal membrane oxygenation placement and prolonged hospitalization. A male infant was born with Apgar score 3' -> 5' with estimate body weight of 2958 gm; he was hospitalized for 10 days and no other complications was found at follow up pediatric outpatient clinic. Conclusion: One of the most dreadful, but rare pregnancy complications is amniotic fluid embolism (AFE). It can cause serious maternal and neonatal morbidity and mortality. Rapid recognition and multidisciplinary team management are essential to maternal and neonatal prognosis.
Recurrent Cardiac Arrests Due to Amniotic Fluid Embolism

Munsef Barakat,Ans Alamami,Ali Ait Hssain

DOI: https://doi.org/10.7759/cureus.22475

2022-02-21

Cureus

Abstract:Amniotic fluid embolism (AFE) is a rare but devastating complication of pregnancy and is associated with high morbidity and mortality. Identifiable maternal risk factors for AFE include older age, multiparity, cesarean section, and placenta previa, while fetal factors include male gender, fetal distress, and death. AFE presents with respiratory distress, seizure, and circulatory collapse and can be complicated with disseminated intravascular coagulopathy, multiorgan failure, and death. In our case, we present a patient who underwent elective cesarean section for placenta previa, which was complicated by sudden cardiac arrest immediately after delivering the placenta in the operating theatre followed by disseminated intravascular coagulation (DIC). The patient developed massive post-partum hemorrhage secondary to the underlying DIC, which required a massive blood transfusion along with platelets, fresh frozen plasma (FFP), and tranexamic acid. The Society of Maternal-Fetal Medicine proposed criteria for the diagnosis of AFE, which include clinical features and laboratory findings. The presence of a DIC picture is considered to be the hallmark finding that helps to differentiate between AFE and other conditions with similar presentation. Treatment of amniotic fluid embolism depends on early recognition and supportive care.
Early recognition and mobilization of resources in managing amniotic fluid embolism for a high-risk obstetric patient: A case report

R Zbeidy,Anh P Le,Sarah M Jacobs,Alexander W M Hall,P Toledo

DOI: https://doi.org/10.1016/j.crwh.2024.e00634

2024-07-10

Abstract:A 33-year-old woman, gravida 3 para 2, at 39 weeks of gestation, undergoing induction of labor, had a seizure. She was transferred to the operating room and underwent a cesarean delivery for non-reassuring fetal status. An amniotic fluid embolism (AFE) was suspected given her cardiovascular collapse, disseminated intravascular coagulation, and early right heart failure. Early mobilization of resources (e.g., blood bank, gynecology oncology, extracorporeal membrane oxygenation) was necessary as the hospital was in a stand-alone building. Biomarkers were sent during the acute event. The creation of an AFE order set is discussed.
Veno-arterial extracorporeal membrane oxygenation for the treatment of obstructive shock caused by venous air embolism: A case report

Gui-Wei Zhu,Yan-Min Li,Wen-Hui Yue,Jian-Xia Sun,Xin Zhou,Ying-Xia Xu,Hai-Bo Wang,Qing-Hai Zhang

DOI: https://doi.org/10.12998/wjcc.v12.i19.4016

2024-07-06

World Journal of Clinical Cases

Abstract:BACKGROUND Venous air embolism (VAE) is a potentially lethal condition, with a reported incidence rate of about 0.13%, and the true incidence may be higher since many VAE are asymptomatic. The current treatments for VAE include Durant's maneuver, aspiration and removal of air through venous catheters, and hyperbaric oxygen therapy. For critically ill patients, use of cardiotonic drugs and chest compressions remain useful strategies. The wider availability of extracorporeal membrane oxygenation (ECMO) has brought a new option for VAE patients. CASE SUMMARY A 53-year-old female patient with VAE presented to the emergency clinic due to abdominal pain with fever for 1 d and unconsciousness for 2 h. One day ago, the patient suffered from abdominal pain, fever, and diarrhea. She suddenly became unconscious after going to the toilet during the intravenous infusion of ciprofloxacin 2 h ago, accompanied by nausea and vomiting, during which a small amount of gastric contents were discharged. She was immediately sent to a local hospital, where cranial and chest computed tomography showed bilateral pneumonia as well as accumulated air visible in the right ventricle and pulmonary artery. The condition deteriorated despite endotracheal intubation, rehydration, and other treatments, and the patient was then transferred to our hospital. Veno-arterial ECMO was applied in our hospital, and the patient's condition gradually improved. The patient was successfully weaned from ECMO and extubated after two days. CONCLUSION ECMO may be an important treatment for patients with VAE in critical condition.

medicine, general & internal
Cardiac magnetic resonance imaging in a patient with amniotic fluid embolism associated with severe cardiopulmonary complications

Yumiko Hosoya,Masafumi Watanabe,Masahiro Terashima,Eisuke Amiya,Tomoko Nakao,Akiko Hasegawa,Hironobu Hyodo,Jiro Ando,Tomoyuki Fujii,Ryozo Nagai,Issei Komuro

DOI: https://doi.org/10.1536/ihj.54.119

Abstract:Amniotic fluid embolism (AFE) is a rare but devastating complication of pregnancy. Acute circulatory failure and obstetric disseminated intravascular coagulopathy are often associated with AFE and lead to poor prognosis of this syndrome. Although many reports of AFE and its cardiopulmonary complications exist, their etiology remains unknown. Classically, it was believed that the fatal cardiopulmonary complication in AFE is due to acute and severe pulmonary hypertension caused by critical obstruction of the pulmonary vessels by embolized amniotic fluid. However, recent hypotheses are suggesting that anaphylactic reaction or a cytokine effect induced by amniotic fluid is the main pathophysiological mechanism. We report a case in which cardiac magnetic resonance imaging was performed at the chronic stage of AFE. Late gadolinium enhancement (LGE) was detected at the mid-wall of the left ventricle with no evidence of pulmonary hypertension. This finding suggests that the pathophysiological mechanism of severe cardiac complications in AFE may include direct left ventricular myocardial injury through an immune reaction or cytokine release, rather than pulmonary embolism.

Immune responses in chickens against Eimeria tenella sporozoite antigen.

CEREBRO-VASCULAR DISEASE AS A CAUSE OF FALLS IN THE ELDERLY.

Rotational Thromboelastometry-Guided Venoarterial Extracorporeal Membrane Oxygenation in the Treatment of Amniotic Fluid Embolism

A novel extraction chromatography and MC-ICP-MS technique for rapid analysis of REE, Sc and Y: Revising CI-chondrite and Post-Archean Australian Shale (PAAS) abundances

Extracorporeal Cardiopulmonary Resuscitation for Amniotic Fluid Embolism

Extracorporeal Membrane Oxygenation in Amniotic Fluid Embolism: A Systematic Review of Case Reports

Resuscitative endovascular balloon occlusion of the aorta: A novel approach for treating amniotic fluid embolism with disseminated intravascular coagulopathy—A report of two cases

A case of amniotic fluid embolism successfully treated by multidisciplinary treatment

Bone mineral density in an outpatient population receiving enzyme-inducing antiepileptic drugs

Extracorporeal Membrane Oxygenation-First Strategy for Acute Life-Threatening Pulmonary Embolism

Case Report: AngioJet Thrombectomy with Extracorporeal Membrane Oxygenation Support for Acute Massive Pulmonary Embolism in a Severe Multiple Trauma Patient

Successful recovery after amniotic fluid embolism in a patient undergoing vacuum-assisted vaginal delivery

Amniotic Fluid Embolism Followed by Cardiac Arrest- A Case Report and Review of the Literature

Early Diagnosis of the Cardiopulmonary Collapse Type of Amniotic Fluid Embolism with Obstetrical Disseminated Intravascular Coagulation during Elective Cesarean Section : A Case Report

Electrochemical biomineralization: the deposition of calcite with chiral morphologies.

Design of new promoters and of a dual-bioreporter based on cross-activation by the two regulatory proteins XylR and HbpR.

Amniotic fluid embolism: A case report of good outcome with timely intensive multidisciplinary team involvement

Recurrent Cardiac Arrests Due to Amniotic Fluid Embolism

Early recognition and mobilization of resources in managing amniotic fluid embolism for a high-risk obstetric patient: A case report

Veno-arterial extracorporeal membrane oxygenation for the treatment of obstructive shock caused by venous air embolism: A case report

Cardiac magnetic resonance imaging in a patient with amniotic fluid embolism associated with severe cardiopulmonary complications